nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—MAOA—conduct disorder	0.78	1	CbGaD
Nicotine—CHAT—autonomic nervous system—conduct disorder	0.0225	0.365	CbGeAlD
Nicotine—CHRNA4—autonomic nervous system—conduct disorder	0.00974	0.158	CbGeAlD
Nicotine—CHRNA5—brain—conduct disorder	0.00346	0.0561	CbGeAlD
Nicotine—CHRNB3—brain—conduct disorder	0.00314	0.0509	CbGeAlD
Nicotine—CHRNA6—brain—conduct disorder	0.00262	0.0425	CbGeAlD
Nicotine—CHRNB4—brain—conduct disorder	0.00238	0.0386	CbGeAlD
Nicotine—CHAT—brain—conduct disorder	0.00218	0.0353	CbGeAlD
Nicotine—CHRNB2—brain—conduct disorder	0.00151	0.0244	CbGeAlD
Nicotine—CHRNA3—brain—conduct disorder	0.00146	0.0237	CbGeAlD
Nicotine—CHRNA2—brain—conduct disorder	0.00136	0.022	CbGeAlD
Nicotine—CHRFAM7A—brain—conduct disorder	0.00118	0.0191	CbGeAlD
Nicotine—CHRNA7—brain—conduct disorder	0.000954	0.0155	CbGeAlD
Nicotine—CYP2A6—brain—conduct disorder	0.000954	0.0155	CbGeAlD
Nicotine—CHRNA4—brain—conduct disorder	0.000941	0.0153	CbGeAlD
Nicotine—SLC22A4—brain—conduct disorder	0.000836	0.0135	CbGeAlD
Nicotine—SLC22A1—brain—conduct disorder	0.000796	0.0129	CbGeAlD
Nicotine—SLC22A3—brain—conduct disorder	0.00076	0.0123	CbGeAlD
Nicotine—CYP19A1—brain—conduct disorder	0.000748	0.0121	CbGeAlD
Nicotine—MAOB—brain—conduct disorder	0.000704	0.0114	CbGeAlD
Nicotine—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000664	0.00418	CbGpPWpGaD
Nicotine—CYP1A2—Methylation—COMT—conduct disorder	0.000654	0.00412	CbGpPWpGaD
Nicotine—CHRNA5—Transmission across Chemical Synapses—COMT—conduct disorder	0.000647	0.00407	CbGpPWpGaD
Nicotine—CHRNA3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000645	0.00406	CbGpPWpGaD
Nicotine—CHRNA5—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000642	0.00404	CbGpPWpGaD
Nicotine—CYP1A1—Estrogen metabolism—COMT—conduct disorder	0.000641	0.00404	CbGpPWpGaD
Nicotine—CHRNA7—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000612	0.00386	CbGpPWpGaD
Nicotine—MAOA—brain—conduct disorder	0.0006	0.00973	CbGeAlD
Nicotine—CHRNA9—Neuronal System—COMT—conduct disorder	0.000598	0.00376	CbGpPWpGaD
Nicotine—CHRNA9—Neuronal System—MAOA—conduct disorder	0.000594	0.00374	CbGpPWpGaD
Nicotine—CHRNA2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000576	0.00363	CbGpPWpGaD
Nicotine—CHRNB2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000567	0.00357	CbGpPWpGaD
Nicotine—SLC22A5—brain—conduct disorder	0.000553	0.00896	CbGeAlD
Nicotine—CHAT—Transmission across Chemical Synapses—COMT—conduct disorder	0.00055	0.00346	CbGpPWpGaD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000547	0.00344	CbGpPWpGaD
Nicotine—CHAT—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000546	0.00344	CbGpPWpGaD
Nicotine—CHAT—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000543	0.00342	CbGpPWpGaD
Nicotine—MAOB—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000543	0.00342	CbGpPWpGaD
Nicotine—CHRNB4—Neuronal System—GABRA2—conduct disorder	0.000541	0.0034	CbGpPWpGaD
Nicotine—CYP2C8—brain—conduct disorder	0.000535	0.00867	CbGeAlD
Nicotine—CHRNB2—Circadian rythm related genes—DRD4—conduct disorder	0.000533	0.00336	CbGpPWpGaD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000528	0.00332	CbGpPWpGaD
Nicotine—CYP2A13—Biological oxidations—COMT—conduct disorder	0.000527	0.00332	CbGpPWpGaD
Nicotine—CYP2A13—Biological oxidations—MAOA—conduct disorder	0.000524	0.0033	CbGpPWpGaD
Nicotine—CHRNB3—Neuronal System—COMT—conduct disorder	0.000523	0.00329	CbGpPWpGaD
Nicotine—CHRNB2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000523	0.00329	CbGpPWpGaD
Nicotine—CYP2A13—Metapathway biotransformation—COMT—conduct disorder	0.00052	0.00328	CbGpPWpGaD
Nicotine—CHRNB3—Neuronal System—MAOA—conduct disorder	0.000519	0.00327	CbGpPWpGaD
Nicotine—CHRNA4—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000499	0.00314	CbGpPWpGaD
Nicotine—CHRNA5—Neuronal System—COMT—conduct disorder	0.000495	0.00312	CbGpPWpGaD
Nicotine—CHRNA3—Neuronal System—GABRA2—conduct disorder	0.000494	0.00311	CbGpPWpGaD
Nicotine—CYP1A1—brain—conduct disorder	0.000494	0.00801	CbGeAlD
Nicotine—CHRNA5—Neuronal System—MAOA—conduct disorder	0.000492	0.0031	CbGpPWpGaD
Nicotine—CHRNA6—Transmission across Chemical Synapses—COMT—conduct disorder	0.00049	0.00309	CbGpPWpGaD
Nicotine—CHRNA6—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000487	0.00306	CbGpPWpGaD
Nicotine—CYP2B6—brain—conduct disorder	0.00048	0.00778	CbGeAlD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000474	0.00299	CbGpPWpGaD
Nicotine—SLC22A2—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.000473	0.00298	CbGpPWpGaD
Nicotine—CHRNA7—Neuronal System—GABRA2—conduct disorder	0.000469	0.00295	CbGpPWpGaD
Nicotine—CYP2E1—brain—conduct disorder	0.000451	0.0073	CbGeAlD
Nicotine—CHRNA2—Neuronal System—GABRA2—conduct disorder	0.000441	0.00278	CbGpPWpGaD
Nicotine—SLC22A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.000441	0.00277	CbGpPWpGaD
Nicotine—CYP1A1—Melatonin metabolism and effects—MAOA—conduct disorder	0.000435	0.00274	CbGpPWpGaD
Nicotine—CHRNB2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000431	0.00272	CbGpPWpGaD
Nicotine—CHRNB2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000428	0.0027	CbGpPWpGaD
Nicotine—CHRNB2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000426	0.00268	CbGpPWpGaD
Nicotine—CYP1A1—Oxidative Stress—MAOA—conduct disorder	0.000423	0.00266	CbGpPWpGaD
Nicotine—CHAT—Neuronal System—COMT—conduct disorder	0.000421	0.00265	CbGpPWpGaD
Nicotine—CHAT—Neuronal System—MAOA—conduct disorder	0.000418	0.00263	CbGpPWpGaD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000411	0.00259	CbGpPWpGaD
Nicotine—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.000409	0.00257	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000387	0.00244	CbGpPWpGaD
Nicotine—CHRNA4—Neuronal System—GABRA2—conduct disorder	0.000383	0.00241	CbGpPWpGaD
Nicotine—CHRNA6—Neuronal System—COMT—conduct disorder	0.000375	0.00236	CbGpPWpGaD
Nicotine—CHRNA6—Neuronal System—MAOA—conduct disorder	0.000373	0.00235	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000357	0.00225	CbGpPWpGaD
Nicotine—CYP2D6—brain—conduct disorder	0.000357	0.00578	CbGeAlD
Nicotine—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.000356	0.00224	CbGpPWpGaD
Nicotine—CHRNB4—Transmission across Chemical Synapses—COMT—conduct disorder	0.00034	0.00214	CbGpPWpGaD
Nicotine—CHRNB4—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000337	0.00212	CbGpPWpGaD
Nicotine—MAOA—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000336	0.00211	CbGpPWpGaD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000335	0.00211	CbGpPWpGaD
Nicotine—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000332	0.00209	CbGpPWpGaD
Nicotine—CHRNB2—Neuronal System—COMT—conduct disorder	0.000331	0.00208	CbGpPWpGaD
Nicotine—CHRNB2—Neuronal System—MAOA—conduct disorder	0.000328	0.00207	CbGpPWpGaD
Nicotine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.000327	0.00206	CbGpPWpGaD
Nicotine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.000316	0.00199	CbGpPWpGaD
Nicotine—CHRNA3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000311	0.00196	CbGpPWpGaD
Nicotine—CHRNA3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000308	0.00194	CbGpPWpGaD
Nicotine—CHRNA7—Transmission across Chemical Synapses—COMT—conduct disorder	0.000295	0.00186	CbGpPWpGaD
Nicotine—CHRNA7—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000293	0.00184	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000291	0.00183	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000291	0.00183	CbGpPWpGaD
Nicotine—MAOB—Biological oxidations—COMT—conduct disorder	0.00029	0.00183	CbGpPWpGaD
Nicotine—MAOB—Biological oxidations—MAOA—conduct disorder	0.000288	0.00182	CbGpPWpGaD
Nicotine—CHAT—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000288	0.00181	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000284	0.00179	CbGpPWpGaD
Nicotine—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.000277	0.00175	CbGpPWpGaD
Nicotine—CHRNA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000277	0.00175	CbGpPWpGaD
Nicotine—CHRNA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000275	0.00173	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000264	0.00167	CbGpPWpGaD
Nicotine—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000264	0.00167	CbGpPWpGaD
Nicotine—CHRNB4—Neuronal System—COMT—conduct disorder	0.00026	0.00164	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00026	0.00164	CbGpPWpGaD
Nicotine—CHRNB4—Neuronal System—MAOA—conduct disorder	0.000258	0.00163	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—GABRA2—conduct disorder	0.000257	0.00162	CbGpPWpGaD
Nicotine—SLC22A4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000247	0.00156	CbGpPWpGaD
Nicotine—CHRNA4—Transmission across Chemical Synapses—COMT—conduct disorder	0.00024	0.00151	CbGpPWpGaD
Nicotine—CHRNA4—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000239	0.0015	CbGpPWpGaD
Nicotine—CHRNA3—Neuronal System—COMT—conduct disorder	0.000238	0.0015	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000237	0.00149	CbGpPWpGaD
Nicotine—CHRNA3—Neuronal System—MAOA—conduct disorder	0.000236	0.00149	CbGpPWpGaD
Nicotine—CHAT—Metabolism—CGA—conduct disorder	0.000235	0.00148	CbGpPWpGaD
Nicotine—CHRNA7—Neuronal System—COMT—conduct disorder	0.000226	0.00142	CbGpPWpGaD
Nicotine—CHRNB2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000226	0.00142	CbGpPWpGaD
Nicotine—CHRNA7—Neuronal System—MAOA—conduct disorder	0.000224	0.00141	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—GABRA2—conduct disorder	0.000217	0.00137	CbGpPWpGaD
Nicotine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000213	0.00134	CbGpPWpGaD
Nicotine—CYP2A6—NRF2 pathway—SLC6A4—conduct disorder	0.000213	0.00134	CbGpPWpGaD
Nicotine—CHRNA2—Neuronal System—COMT—conduct disorder	0.000212	0.00134	CbGpPWpGaD
Nicotine—CHRNA2—Neuronal System—MAOA—conduct disorder	0.000211	0.00133	CbGpPWpGaD
Nicotine—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000209	0.00132	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.000203	0.00128	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—CGA—conduct disorder	0.0002	0.00126	CbGpPWpGaD
Nicotine—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000197	0.00124	CbGpPWpGaD
Nicotine—SLC22A3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000186	0.00117	CbGpPWpGaD
Nicotine—SLC22A5—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000186	0.00117	CbGpPWpGaD
Nicotine—CHRNB2—Circadian rythm related genes—EP300—conduct disorder	0.000184	0.00116	CbGpPWpGaD
Nicotine—CHRNA4—Neuronal System—COMT—conduct disorder	0.000184	0.00116	CbGpPWpGaD
Nicotine—CHRNA4—Neuronal System—MAOA—conduct disorder	0.000183	0.00115	CbGpPWpGaD
Nicotine—MAOA—Biological oxidations—COMT—conduct disorder	0.000182	0.00115	CbGpPWpGaD
Nicotine—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000181	0.00114	CbGpPWpGaD
Nicotine—CYP19A1—Biological oxidations—COMT—conduct disorder	0.000178	0.00112	CbGpPWpGaD
Nicotine—CHRNB4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000178	0.00112	CbGpPWpGaD
Nicotine—CYP19A1—Biological oxidations—MAOA—conduct disorder	0.000176	0.00111	CbGpPWpGaD
Nicotine—CYP19A1—Metapathway biotransformation—COMT—conduct disorder	0.000175	0.0011	CbGpPWpGaD
Nicotine—MAOA—Transmission across Chemical Synapses—COMT—conduct disorder	0.000162	0.00102	CbGpPWpGaD
Nicotine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000161	0.00102	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000159	0.001	CbGpPWpGaD
Nicotine—CHRNA7—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000154	0.000971	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000151	0.000952	CbGpPWpGaD
Nicotine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000148	0.000934	CbGpPWpGaD
Nicotine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000147	0.000926	CbGpPWpGaD
Nicotine—CYP2A6—Biological oxidations—COMT—conduct disorder	0.000141	0.000891	CbGpPWpGaD
Nicotine—CYP2A6—Biological oxidations—MAOA—conduct disorder	0.00014	0.000885	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000137	0.00086	CbGpPWpGaD
Nicotine—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000136	0.000854	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00013	0.000817	CbGpPWpGaD
Nicotine—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00013	0.000817	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000127	0.000802	CbGpPWpGaD
Nicotine—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000126	0.000796	CbGpPWpGaD
Nicotine—CHRNA4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000126	0.000792	CbGpPWpGaD
Nicotine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000126	0.000791	CbGpPWpGaD
Nicotine—MAOA—Neuronal System—COMT—conduct disorder	0.000124	0.000779	CbGpPWpGaD
Nicotine—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000117	0.000736	CbGpPWpGaD
Nicotine—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.000115	0.000723	CbGpPWpGaD
Nicotine—CYP2B6—Biological oxidations—COMT—conduct disorder	0.000114	0.000719	CbGpPWpGaD
Nicotine—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.000113	0.000714	CbGpPWpGaD
Nicotine—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.000113	0.000709	CbGpPWpGaD
Nicotine—CYP2E1—Biological oxidations—COMT—conduct disorder	0.000112	0.000704	CbGpPWpGaD
Nicotine—CYP2E1—Biological oxidations—MAOA—conduct disorder	0.000111	0.000699	CbGpPWpGaD
Nicotine—CYP2E1—Metapathway biotransformation—COMT—conduct disorder	0.00011	0.000694	CbGpPWpGaD
Nicotine—MAOB—Metabolism—CGA—conduct disorder	0.00011	0.000693	CbGpPWpGaD
Nicotine—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000109	0.000686	CbGpPWpGaD
Nicotine—CHAT—Metabolism—COMT—conduct disorder	0.000106	0.000668	CbGpPWpGaD
Nicotine—CYP1A1—Biological oxidations—COMT—conduct disorder	0.000105	0.000664	CbGpPWpGaD
Nicotine—CHAT—Metabolism—MAOA—conduct disorder	0.000105	0.000663	CbGpPWpGaD
Nicotine—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.000105	0.000659	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—COMT—conduct disorder	0.000105	0.000659	CbGpPWpGaD
Nicotine—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.000104	0.000655	CbGpPWpGaD
Nicotine—SLC22A2—Neuronal System—MAOA—conduct disorder	0.000104	0.000654	CbGpPWpGaD
Nicotine—CHAT—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000102	0.000643	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—COMT—conduct disorder	9.75e-05	0.000614	CbGpPWpGaD
Nicotine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	9.69e-05	0.000611	CbGpPWpGaD
Nicotine—SLC22A1—Neuronal System—MAOA—conduct disorder	9.68e-05	0.00061	CbGpPWpGaD
Nicotine—CYP2C8—Biological oxidations—COMT—conduct disorder	9.66e-05	0.000608	CbGpPWpGaD
Nicotine—CYP2C8—Biological oxidations—MAOA—conduct disorder	9.59e-05	0.000604	CbGpPWpGaD
Nicotine—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	9.53e-05	0.0006	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—CGA—conduct disorder	9.31e-05	0.000586	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—COMT—conduct disorder	9.02e-05	0.000568	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	8.97e-05	0.000565	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—MAOA—conduct disorder	8.95e-05	0.000564	CbGpPWpGaD
Nicotine—CYP2C19—Biological oxidations—COMT—conduct disorder	8.62e-05	0.000543	CbGpPWpGaD
Nicotine—CYP2C19—Biological oxidations—MAOA—conduct disorder	8.56e-05	0.000539	CbGpPWpGaD
Nicotine—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	8.51e-05	0.000536	CbGpPWpGaD
Nicotine—CYP19A1—Integrated Breast Cancer Pathway—EP300—conduct disorder	8.46e-05	0.000533	CbGpPWpGaD
Nicotine—MAOA—SIDS Susceptibility Pathways—EP300—conduct disorder	8.45e-05	0.000532	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	8.28e-05	0.000521	CbGpPWpGaD
Nicotine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	8.28e-05	0.000521	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	8.22e-05	0.000518	CbGpPWpGaD
Nicotine—CYP2D6—Biological oxidations—COMT—conduct disorder	7.93e-05	0.0005	CbGpPWpGaD
Nicotine—CYP2D6—Biological oxidations—MAOA—conduct disorder	7.88e-05	0.000496	CbGpPWpGaD
Nicotine—CYP2C9—Biological oxidations—COMT—conduct disorder	7.86e-05	0.000495	CbGpPWpGaD
Nicotine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	7.82e-05	0.000493	CbGpPWpGaD
Nicotine—CYP2C9—Biological oxidations—MAOA—conduct disorder	7.81e-05	0.000492	CbGpPWpGaD
Nicotine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	7.76e-05	0.000488	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	7.34e-05	0.000462	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CGA—conduct disorder	6.9e-05	0.000435	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CGA—conduct disorder	6.73e-05	0.000424	CbGpPWpGaD
Nicotine—CYP1A2—Biological oxidations—COMT—conduct disorder	6.72e-05	0.000423	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	6.69e-05	0.000421	CbGpPWpGaD
Nicotine—CYP1A2—Biological oxidations—MAOA—conduct disorder	6.67e-05	0.00042	CbGpPWpGaD
Nicotine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	6.63e-05	0.000417	CbGpPWpGaD
Nicotine—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	6.46e-05	0.000407	CbGpPWpGaD
Nicotine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	6.33e-05	0.000398	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CGA—conduct disorder	5.84e-05	0.000368	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	5.72e-05	0.00036	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CGA—conduct disorder	5.44e-05	0.000343	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CGA—conduct disorder	5.36e-05	0.000337	CbGpPWpGaD
Nicotine—CYP3A4—Biological oxidations—COMT—conduct disorder	5.19e-05	0.000327	CbGpPWpGaD
Nicotine—CYP3A4—Biological oxidations—MAOA—conduct disorder	5.15e-05	0.000324	CbGpPWpGaD
Nicotine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	5.12e-05	0.000322	CbGpPWpGaD
Nicotine—MAOB—Metabolism—COMT—conduct disorder	4.97e-05	0.000313	CbGpPWpGaD
Nicotine—MAOB—Metabolism—MAOA—conduct disorder	4.93e-05	0.000311	CbGpPWpGaD
Nicotine—CHAT—Metabolism—EP300—conduct disorder	4.55e-05	0.000286	CbGpPWpGaD
Nicotine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	4.36e-05	0.000274	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CGA—conduct disorder	4.32e-05	0.000272	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CGA—conduct disorder	4.24e-05	0.000267	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—COMT—conduct disorder	4.2e-05	0.000265	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—MAOA—conduct disorder	4.17e-05	0.000263	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CGA—conduct disorder	3.99e-05	0.000251	CbGpPWpGaD
Nicotine—CYP2A13—Metabolism—EP300—conduct disorder	3.87e-05	0.000244	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CGA—conduct disorder	3.66e-05	0.000231	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CGA—conduct disorder	3.27e-05	0.000206	CbGpPWpGaD
Nicotine—MAOA—Metabolism—COMT—conduct disorder	3.12e-05	0.000196	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—COMT—conduct disorder	3.04e-05	0.000191	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—MAOA—conduct disorder	3.02e-05	0.00019	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CGA—conduct disorder	3.01e-05	0.000189	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CGA—conduct disorder	2.98e-05	0.000188	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.93e-05	0.000184	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—COMT—conduct disorder	2.64e-05	0.000166	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—MAOA—conduct disorder	2.62e-05	0.000165	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CGA—conduct disorder	2.55e-05	0.00016	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—COMT—conduct disorder	2.46e-05	0.000155	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—MAOA—conduct disorder	2.44e-05	0.000154	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—COMT—conduct disorder	2.42e-05	0.000152	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—MAOA—conduct disorder	2.4e-05	0.000151	CbGpPWpGaD
Nicotine—MAOB—Metabolism—EP300—conduct disorder	2.13e-05	0.000134	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CGA—conduct disorder	1.96e-05	0.000124	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—COMT—conduct disorder	1.95e-05	0.000123	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—MAOA—conduct disorder	1.94e-05	0.000122	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—COMT—conduct disorder	1.91e-05	0.00012	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—MAOA—conduct disorder	1.9e-05	0.00012	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—COMT—conduct disorder	1.8e-05	0.000114	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—EP300—conduct disorder	1.8e-05	0.000113	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—MAOA—conduct disorder	1.79e-05	0.000113	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.74e-05	0.000109	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—COMT—conduct disorder	1.65e-05	0.000104	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—MAOA—conduct disorder	1.64e-05	0.000103	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.59e-05	0.0001	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—COMT—conduct disorder	1.47e-05	9.29e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—MAOA—conduct disorder	1.46e-05	9.22e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.42e-05	8.94e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—COMT—conduct disorder	1.36e-05	8.54e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—MAOA—conduct disorder	1.35e-05	8.48e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—COMT—conduct disorder	1.34e-05	8.47e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—EP300—conduct disorder	1.34e-05	8.41e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—MAOA—conduct disorder	1.34e-05	8.41e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—EP300—conduct disorder	1.3e-05	8.21e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.3e-05	8.16e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—COMT—conduct disorder	1.15e-05	7.24e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—MAOA—conduct disorder	1.14e-05	7.19e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—EP300—conduct disorder	1.13e-05	7.12e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.11e-05	6.97e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—EP300—conduct disorder	1.05e-05	6.63e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—EP300—conduct disorder	1.04e-05	6.53e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—COMT—conduct disorder	8.87e-06	5.59e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—MAOA—conduct disorder	8.81e-06	5.55e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—EP300—conduct disorder	8.37e-06	5.27e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—EP300—conduct disorder	8.2e-06	5.16e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—EP300—conduct disorder	7.73e-06	4.87e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—EP300—conduct disorder	7.09e-06	4.46e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—EP300—conduct disorder	6.33e-06	3.98e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—EP300—conduct disorder	5.82e-06	3.66e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—EP300—conduct disorder	5.77e-06	3.63e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—EP300—conduct disorder	4.93e-06	3.1e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—EP300—conduct disorder	3.8e-06	2.4e-05	CbGpPWpGaD
